Article Details

Iantrek: $42 Million Series C Raised For Interventional Glaucoma Therapy

Retrieved on: 2025-08-23 17:22:36

Tags for this article:

Click the tags to see associated articles and topics

Iantrek: $42 Million Series C Raised For Interventional Glaucoma Therapy. View article details on hiswai:

Excerpt

... U.S. Venture Partners (USVP), with participation from aMoon Fund and existing investors, including Visionary Ventures and Sectoral Asset Management.

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo